Kaleido Biosciences(KLDO)
$0.000.00 (0.00%)
KLDO
Kaleido Biosciences stock drug pipeline
$0.00
At close:0.00 (0.00%)
Kaleido Biosciences (KLDO) Drug Pipeline
196 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Kb195 | Urea Cycle Disorder | Phase II | Terminated | UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder | Apr 29, 2019 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Kb195 | Phase II | Urea Cycle Disorder | Terminated | UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder | Apr 29, 2019 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Kaleido Biosciences (KLDO) have in its pipeline
Kaleido Biosciences KLDO is currently developing the following drugs: Kb195. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
